Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Nov;116(6):2724–2728. doi: 10.1111/j.1476-5381.1995.tb17233.x

5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices.

C Bianchi 1, L Ferraro 1, S Tanganelli 1, M Morari 1, G Spalluto 1, M Simonato 1, L Beani 1
PMCID: PMC1909134  PMID: 8590996

Abstract

1. The effect of nicotine on endogenous basal GABA outflow was studied in guinea-pig cerebral cortex slices. 2. Nicotine 1.86-18.6 mumol l-1 significantly decreased the basal, tetrodotoxin-sensitive GABA efflux, whereas at higher concentrations (186-620 mumol l-1) nicotine increased it. The inhibition was prevented by mecamylamine while the facilitation was blocked by mecamylamine, (+)-tubocurarine and tetrodotoxin. 3. The effect of nicotine was due to an indirect 5-hydroxytryptaminergic action. In fact, MDL 72222 (1 mumol l-1) completely prevented the alkaloid inhibition and methysergide (1 mumol l-1) reversed the facilitation into inhibition; concomitant treatment with methysergide and MDL 72222 antagonized the effect of nicotine at 186 mumol l-1 4. Lower concentrations of 5-HT (3-10 mumol l-1) decreased, whereas higher concentrations (30-100 mumol l-1) increased, spontaneous GABA outflow. The inhibition of GABA efflux was prevented by MDL 72222 whereas the facilitation was reversed by methysergide (1 mumol l-1) into inhibition, and prevented by MDL 72222 1 mumol l-11. 5. These results suggest that, by activating nicotinic receptors present on 5-hydroxytryptaminergic terminals, nicotine releases 5-HT which, in turn, inhibits or increases the secretory activity of cortical GABA interneurones via 5-HT3 and methysergide-sensitive receptors, respectively.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour D. J. Influence of nicotine on the release of monoamines in the brain. Prog Brain Res. 1989;79:165–172. doi: 10.1016/s0079-6123(08)62476-0. [DOI] [PubMed] [Google Scholar]
  2. Balfour D. J. The effects of nicotine on brain neurotransmitter systems. Pharmacol Ther. 1982;16(2):269–282. doi: 10.1016/0163-7258(82)90058-4. [DOI] [PubMed] [Google Scholar]
  3. Beani L., Bianchi C., Giacomelli A., Tamberi F. Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol. 1978 Mar 15;48(2):179–193. doi: 10.1016/0014-2999(78)90327-8. [DOI] [PubMed] [Google Scholar]
  4. Beani L., Bianchi C., Nilsson L., Nordberg A., Romanelli L., Sivilotti L. The effect of nicotine and cytisine on 3H-acetylcholine release from cortical slices of guinea-pig brain. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):293–296. doi: 10.1007/BF00634252. [DOI] [PubMed] [Google Scholar]
  5. Beani L., Tanganelli S., Antonelli T., Bianchi C. Noradrenergic modulation of cortical acetylcholine release is both direct and gamma-aminobutyric acid-mediated. J Pharmacol Exp Ther. 1986 Jan;236(1):230–236. [PubMed] [Google Scholar]
  6. Beani L., Tanganelli S., Antonelli T., Ferraro L., Morari M., Spalluto P., Nordberg A., Bianchi C. Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]-D-aspartate and endogenous GABA in freely moving guinea-pigs. Br J Pharmacol. 1991 Sep;104(1):15–20. doi: 10.1111/j.1476-5381.1991.tb12377.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bertilsson L., Costa E. Mass fragmentographic quantitation of glutamic acid and gamma-aminobutyric acid in cerebellar nuclei and sympathetic ganglia of rats. J Chromatogr. 1976 Apr 7;118(3):395–402. doi: 10.1016/s0021-9673(00)82177-9. [DOI] [PubMed] [Google Scholar]
  8. Carboni E., Acquas E., Frau R., Di Chiara G. Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol. 1989 May 30;164(3):515–519. doi: 10.1016/0014-2999(89)90259-8. [DOI] [PubMed] [Google Scholar]
  9. Cloëz-Tayarani I., Harel-Dupas C., Fillion G. Inhibition of [3H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents. Fundam Clin Pharmacol. 1992;6(8-9):333–341. doi: 10.1111/j.1472-8206.1992.tb00128.x. [DOI] [PubMed] [Google Scholar]
  10. Ferraro L., Tanganelli S., Caló G., Antonelli T., Fabrizi A., Acciarri N., Bianchi C., Beani L., Simonato M. Noradrenergic modulation of gamma-aminobutyric acid outflow from the human cerebral cortex. Brain Res. 1993 Nov 26;629(1):103–108. doi: 10.1016/0006-8993(93)90487-8. [DOI] [PubMed] [Google Scholar]
  11. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol. 1986 Dec 16;132(2-3):337–338. doi: 10.1016/0014-2999(86)90629-1. [DOI] [PubMed] [Google Scholar]
  12. Limberger N., Späth L., Starke K. A search for receptors modulating the release of gamma-[3H]aminobutyric acid in rabbit caudate nucleus slices. J Neurochem. 1986 Apr;46(4):1109–1117. doi: 10.1111/j.1471-4159.1986.tb00625.x. [DOI] [PubMed] [Google Scholar]
  13. Lukas R. J. Nicotinic acetylcholine receptor diversity: agonist binding and functional potency. Prog Brain Res. 1989;79:117–127. doi: 10.1016/s0079-6123(08)62471-1. [DOI] [PubMed] [Google Scholar]
  14. Léna C., Changeux J. P., Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J Neurosci. 1993 Jun;13(6):2680–2688. doi: 10.1523/JNEUROSCI.13-06-02680.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McHugh D., Beech D. J. Inhibition of delayed rectifier K(+)-current by levcromakalim in single intestinal smooth muscle cells: effects of cations and dependence on K(+)-flux. Br J Pharmacol. 1995 Jan;114(2):391–399. doi: 10.1111/j.1476-5381.1995.tb13239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nisell M., Nomikos G. G., Svensson T. H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 1994 Jan;16(1):36–44. doi: 10.1002/syn.890160105. [DOI] [PubMed] [Google Scholar]
  17. Nordberg A., Romanelli L., Sundwall A., Bianchi C., Beani L. Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs. Br J Pharmacol. 1989 Sep;98(1):71–78. doi: 10.1111/j.1476-5381.1989.tb16864.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pérez de la Mora M., Méndez-Franco J., Salceda R., Aguirre J. A., Fuxe K. Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain. Acta Physiol Scand. 1991 Feb;141(2):241–250. doi: 10.1111/j.1748-1716.1991.tb09074.x. [DOI] [PubMed] [Google Scholar]
  19. Ribeiro E. B., Bettiker R. L., Bogdanov M., Wurtman R. J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993 Sep 10;621(2):311–318. doi: 10.1016/0006-8993(93)90121-3. [DOI] [PubMed] [Google Scholar]
  20. Rice M. E., Gerhardt G. A., Hierl P. M., Nagy G., Adams R. N. Diffusion coefficients of neurotransmitters and their metabolites in brain extracellular fluid space. Neuroscience. 1985 Jul;15(3):891–902. doi: 10.1016/0306-4522(85)90087-9. [DOI] [PubMed] [Google Scholar]
  21. Rosecrans J. A., Schechter M. D. Brain area nicotine levels in male and female rats of two strains. Arch Int Pharmacodyn Ther. 1972 Mar;196(1):46–54. [PubMed] [Google Scholar]
  22. Toth E., Vizi E. S., Lajtha A. Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology. 1993 Aug;32(8):827–832. doi: 10.1016/0028-3908(93)90192-6. [DOI] [PubMed] [Google Scholar]
  23. Westfall T. C., Grant H., Perry H. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen Pharmacol. 1983;14(3):321–325. doi: 10.1016/0306-3623(83)90037-x. [DOI] [PubMed] [Google Scholar]
  24. Wonnacott S., Irons J., Rapier C., Thorne B., Lunt G. G. Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res. 1989;79:157–163. doi: 10.1016/s0079-6123(08)62475-9. [DOI] [PubMed] [Google Scholar]
  25. Yamamoto I., Inoki R., Tamari Y., Iwatsubo K. Effect of reserpine on brain levels of 14C-nicotine in relation to nicotine-induced convulsions. Arch Int Pharmacodyn Ther. 1967 Mar;166(1):102–109. [PubMed] [Google Scholar]
  26. de la Garza R., Freedman R., Hoffer J. Nicotine-induced inhibition of cerebellar Purkinje neurons: specific actions of nicotine and selective blockade by mecamylamine. Neuropharmacology. 1989 May;28(5):495–501. doi: 10.1016/0028-3908(89)90085-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES